News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Synergy CHC Corp. (SNYR) is scheduled to release its Q2'26 earnings on August 13, with an estimated revenue of $8.00 million and an EPS of ($0.01). The report will provide insight into the company's financial performance compared to previous quarters and analyst expectations.
Synergy CHC Corp. (NASDAQ: SNYR) has received a notice of default on its term loan due to a missed interest payment, leading to the termination of a prior forbearance agreement. The company now owes a forbearance fee and has approximately $17.6 million in principal …
This article announces the filing of a Form 8K by Synergy CHC Corp on August 11, as reported by Investing.com. It is a brief, factual notification typical of financial news services, indicating a corporate event that necessitates a filing with the SEC. The article …
This article provides an earnings forecast for Synergy CHC Corp (SNYR), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 58 out of 156 in the Pharmaceuticals industry, with two analysts recommending a "Buy" trend. …
Birchcliff Energy Ltd. CALGARY, Alberta, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Birchcliff Energy Ltd. ("Birchcliff" or the "Corporation") (TSX: BIR) is pleased to announce the appointment of Rebecca Schulz to the Corporation's Board of Directors, effective today. Ms. Schulz is a public affairs and …
New to The Street has launched a significant television commercial campaign for Synergy CHC Corp (NASDAQ:SNYR), makers of Focus Factor®, a leading brain health supplement. The campaign includes over 1,000 commercials on national and local networks, NYC market penetration, NewsOut Video PR coverage, distribution …
Synergy CHC announced that Costco will discontinue carrying its FOCUSfactor products, a partnership that spanned over 16 years. This decision is significant as Costco represented approximately 58% of Synergy CHC's net revenue for the fiscal year ended December 31, 2025. The company expects this …
This article provides a risk assessment for Synergy CHC Corp (SNYR), indicating a current risk score of 2.64, ranking 121 out of 155 in the Pharmaceuticals industry. The company's beta of 0.00 suggests it tends to underperform during market uptrends but experiences smaller declines …
This article provides an overview of Synergy CHC Corp's (SNYR) institutional confidence score and shareholder activity as of July 31, 2026. It lists key institutional shareholders and their shareholdings, noting changes for some, such as Ross (Jack) increasing holdings and Sanders Morris LLC decreasing …
This article provides a valuation analysis for Synergy CHC Corp (SNYR), indicating a current valuation score of 9.10, which ranks 34 out of 155 in the Pharmaceuticals industry. The P/E ratio is noted as -0.11, significantly below its recent high and above its recent …
The financial health of Synergy CHC Corp (SNYR) is currently rated as weak with a score of 7.16, placing it 122nd out of 155 companies in the Pharmaceuticals industry. The company's latest quarterly revenue saw a year-over-year decrease of 32.77%, and its net profit …
This article first appeared on GuruFocus. Release Date: July 28, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Inchcape PLC (IHCPF) achieved a 9% revenue growth in the first half of 2026, driven …
TradingKey provides a comprehensive stock analysis for Synergy CHC Corp (SNYR), indicating stable fundamentals and high growth potential despite a recent turnaround to loss. The stock is considered fairly valued and has high institutional ownership, with analysts rating it as a "Buy" and expecting …
This article provides a technical analysis of Synergy CHC Corp (SNYR), detailing its price momentum score, support and resistance levels, and various technical indicators. It shows that SNYR's current price momentum score is 4.29, ranking 54th in the Pharmaceuticals industry, with the stock trading …
This article provides a detailed revenue breakdown for Synergy CHC Corp (SNYR), categorizing its income by business segments and geographical regions. It shows that Nutraceuticals account for $8.01 million in revenue, while 'Licenses revenue' is $0.00. Geographically, the United States contributes the majority of …
Search by ticker symbol or company name and select a result to open its chart.